Coriell Institute for Medical Research
Coriell Institute of Medical Research
  • Request a Quote
  • Donate
  • Login
  • View Cart
Sample Catalog | Custom Services | Core Facilities | Genomic Data Search
  • Biobank
    • NIGMS
    • NINDS
    • NIA
    • NHGRI
    • NEI
    • Allen Cell Collection
    • Rett Syndrome iPSC Collection
    • Autism Research Resource
    • HD Community Biorepository
    • CDC Cell and DNA
    • J. Craig Venter Institute
    • Orphan Disease Center Collection
    • All Biobanks
  • Research
    • Overview
    • Meet Our Scientists
      • Our Faculty
      • Our Scientific Staff
    • Camden Cancer Research Center
    • Epigenetic Therapies SPORE
    • Core Facilities
    • Epigenomics
    • Camden Opioid Research Initiative (CORI)
    • The Issa & Jelinek Lab
    • The Jian Huang Lab
    • The Luke Chen Lab
      • The Lab
      • The Team
      • Publications
    • The Scheinfeldt Lab
    • The Shumei Song Lab
    • The Nora Engel Lab
      • The Lab
      • The Team
      • Publications
    • Publications
  • Services
    • Overview
    • Biobanking Services
      • Core Services
      • Project Management
      • Research Support Services
      • Sample Cataloging
      • Sample Collection Kits
      • Sample Data Management
      • Sample Distribution
      • Sample Management
      • Sample Procurement
      • Sample Storage
    • Bioinformatics and Biostatistics Services
    • Cellular and Molecular Services
      • Biomarker Research Solutions
      • Cell Culture
      • Nucleic Acid Isolation and Quality Control
    • Clinical Trial Support
      • Overview
      • Sample Collection
      • Data Management
      • Sample Processing and QC
      • Storage and Distribution
      • Biomarker Services
      • Data Analaysis
    • Core Facilties
      • Overview
      • Animal and Xenograft
      • Bioinformatics and Biostatistics
      • Cell Imaging
      • CRISPR Gene Engineering
      • Flow Cytometry and Cell Sorting
      • Genomics and Epigenomics
      • iPSC - Induced Pluripotent Stem Cells
      • Organoids
    • Coriell Marketplace
    • Genomic, Epigenomic and Multiomics Services
    • Stem Cells and iPSC Services
      • Core Services
      • Reprogramming
      • Characterization and Quality Control
      • Differentiated Cell Lines
      • iPSC-Derived Organoids
      • iPSC Expansion
      • iPSC Gene Editing
  • Ordering
    • Stem Cells
    • Cell Lines
    • DNA and RNA
    • Featured Products
      • FFPE
      • HMW DNA
    • Genomic Data Search
    • Search by Catalog ID
    • Help
      • Create Account
      • Order Online
      • Ordering FAQ
      • FAQs/Culture Instructions
      • Reference Materials
        • Biobanks
        • NIGMS Repository
        • NHGRI Repository
        • NINDS Repository
        • NIA Repository
        • NIST
        • GeT-RM
      • Secondary Distribution Policies
      • MTA Assurance Form
      • Shipment Policy
      • Contact Customer Service
  • About Us
    • Our History
    • Meet Our Team
    • Meet Our Board
    • Education
      • Science Fair
      • Summer Experience
      • Outreach
      • Research Program Internship
    • Press Room
      • Press Releases
      • Coriell Blog
      • Annual Report
    • Careers
      • Working at Coriell
    • Giving
      • Donate
      • Giving FAQ
    • Contact Us
    • Legal Notice
  • Login View Cart
search submit
GM28857 Fibroblast from Skin, Skin

Description:

UBA5-RELATED DISORDER
UBIQUITIN-LIKE MODIFIER ACTIVATING ENZYME 5; UBA5

Affected:

Yes

Sex:

Male

Age:

2 YR (At Sampling)

  • Overview
  • Characterizations
  • Phenotypic Data
  • External Links
  • Culture Protocols

Overview

back to top
Repository NIGMS Human Genetic Cell Repository
Subcollection Heritable Diseases
PIGI Consented Sample
Biopsy Source Skin
Cell Type Fibroblast
Tissue Type Skin
Transformant Untransformed
Sample Source Fibroblast from Skin, Skin
Race Asian
Ethnicity Not Hispanic/Latino
Ethnicity Vietnamese
Country of Origin USA
Family Member 1
Family History N
Relation to Proband proband
Confirmation Molecular characterization before cell line submission to CCR
Species Homo sapiens
Common Name Human
Remarks Clinically affected. See "Phenotypic Data" tab; LCL sample- GM28942; unaffected carrier parents are GM28856(fibro)/GM28954(LCL) and GM28858 (fibro)/GM28953(LCL)

Characterizations

back to top
PDL at Freeze 6.6
Passage Frozen 2
 
Gene UBA5
Chromosomal Location 3q22.1
Allelic Variant 1 Mel > Val; UBA5 Related Disorders
Identified Mutation c.169 A>G (p.Met57Val); UBA5 Related Disorders
 
Gene UBA5
Chromosomal Location 3q22.1
Allelic Variant 1 Gln>Leu; UBA5 Related Disorders
Identified Mutation c.935 A>T (p.Gln312Leu); UBA5 Related Disorders
 
Gene COQ7
Chromosomal Location 16p12.3
Allelic Variant 1 ; COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8
Identified Mutation c.508-8T>G
 
Gene AP4S1
Chromosomal Location 14q12
Allelic Variant 1 Trp114X; Spastic paraplegia 52, autosomal recessive
Identified Mutation c.341G>A (p.Trp114X)

Phenotypic Data

back to top
Demographic Data
Relation to Proband proband
Age at Sampling 2 YR
Sex Male
Age of Onset(If not a control) 3 MO
Age at Diagnosis(If not a control) 1 YR
Hispanic or Latino/Not Hispanic or Latino Not Hispanic/Latino
Racial Category Asian
Country USA
 
Data Elements
Clinical Element Type: General NIGMS Catalog Remarks
  (Baseline)
Mutation Information
Gene, variant, consequence, and exon number:  EXOME SEQUENCING REVEALED TWO HETEROZYGOUS, LIKELY PATHOGENIC MUTATIONS IN THE UBA5 GENE (NM_024818.3): C.169 A>G (P.M57V), INHERITED FROM THE MOTHER AND C.935 A>T (P.Q312L) INHERITED FROM THE FATHER
Zygosity:  Heterozygous
Other variants:  A CEREBRAL PALSY SPECTRUM DISORDER PANEL REVEALED TWO HETEROZYGOUS MUTATIONS OF UNCERTAIN SIGNIFICANCE: ONE IN THE AP4S1 GENE C.341G>A (P.TRP114*) AND ANOTHER ON THE COQ7 GENE C.508-8T>G (INTRONIC). MICROARRAY ANALYSIS ALSO REVEALED A VARIANT OF UNKNOWN SIGNIFICANCE: ARR[GRCH37] 4Q13.2Q13.3(6927638_71275343)X1. THE ABNORMALITY IS CHARACTERIZED BY A COPY LOSS OF 63 OLIGONUCLEOTIDE PROBES IN THE LONG ARM OF ONE COPY OF CHROMOSOME 4 FROM Q13.2 TO Q13.3
Age of Symptom Onset and Age at Diagnosis
Age of Symptom Onset:  3 MONTHS
Age at Diagnosis:  1 YEAR
In Utero History Information
Birth History Information
Dysmorphic Features
Neurological Symptoms
Cerebral palsy
Dystonia
Hypotonia
Additional Information:  SPASTIC QUADRIPLEGIA CEREBRAL PALSY; ABNORMAL EEG; FAILURE TO THRIVE; DYSPHAGIA, NEUROLOGICAL MOVEMENT DISORDER, BODY JERKS IN SLEEP
Optical and Audiological Symptoms
Additional Information:  CROSSED EYES, ESOPHORIA
Musculoskeletal Symptoms
Additional Information:  MILD COXA VALGA WITH NORMAL FEMORAL HEAD COVERAGE
Developmental Milestones
Global developmental delay
Additional Information:  STARING SPELLS
Gastrointestinal Symptoms
Eating difficulties
Additional Information:  GERD, VOMITTING, GTUBE DEPENDENT FEEDING
Genitourinary Symptoms
Respiratory and Cardiovascular Symptoms
Additional Information:  TACHYPNEA; CHEST X-RAY REVEALED PATCHY BILATERAL NODULAR OPACITIES, AIRWAY THICKENING, AND PROMINENT PULMONARY ARTERIAL CONTOUR
Cognitive and Behavioral Symptoms
Sleep disturbances
Additional Information:  BEHAVIORAL INSOMNIA, SNORING, SEVERE DELAYED SLEEP ONSET
Additional Information
Testing Performed
Treatments and Assistive Devices
Wheelchair or ambulation devices
Orthotics
Communication or learning devices
Additional Testing:  DIAGNOSTIC PSG, EEG, LARYNGOSCOPY, SPECIAL EYE EVALUATION, REFRACTION
Medications
 DIAZEPAM, BACLOFEN
Family History
Remarks Clinically affected. See "Phenotypic Data" tab; LCL sample- GM28942; unaffected carrier parents are GM28856(fibro)/GM28954(LCL) and GM28858 (fibro)/GM28953(LCL)

External Links

back to top
Gene Cards UBA5
NCBI GTR 610552 UBIQUITIN-LIKE MODIFIER ACTIVATING ENZYME 5; UBA5
OMIM 610552 UBIQUITIN-LIKE MODIFIER ACTIVATING ENZYME 5; UBA5

Culture Protocols

back to top
Cumulative PDL at Freeze 6.6
Passage Frozen 2
Split Ratio 1:4
Temperature 37 C
Percent CO2 5%
Percent O2 3%
Medium Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent
Serum 15% fetal bovine serum Not inactivated
Supplement -
Pricing
International/Commercial/For-profit:
$373.00USD
U.S. Academic/Non-profit/Government:
$216.00USD
Add to Cart
How to Order
  • Ordering Instructions
  • MTA / Assurance Form
  • Statement of Research Intent Form
Related Products
Same Family
  • NIGMS00009
Miscellaneous
  • DNA on Demand
  • Custom Services

Our mission is to prevent and cure disease through biomedical research.

CONTACT US

CUSTOMER SERVICE
customerservice@coriell.org (800) 752-3805 • (856) 757-4848
Subscribe to our newsletter here

Coriell Institute for Medical Research
403 Haddon Avenue Camden, NJ 08103, USA (856) 966-7377

Ⓒ 2025 Coriell Institute. All rights reserved.

  • Facebook
  • Linkedin
  • Youtube